Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439771
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-16
Brief Title:
A Phase 2 Study to Evaluate the Efficacy Safety and Pharmacokinetics of YL202 in Patients With BC
Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Organization:
MediLink Therapeutics Suzhou Co Ltd
Organization Data
Organization:
MediLink Therapeutics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
YL202-CN-202-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None